Most recent update: Sunday, April 29, 2018 - 14:56

You are here


andexanet stops dangerous bleeding factor Xa inhibitors patients

The experimental drug andexanet was associated with control of serious bleeding in patients taking a common class of anticoagulants known as Factor Xa inhibitors, according to interim clinical trial results presented at the American College of Cardiology's 67th Annual Scientific Session. Millions of patients take Factor Xa inhibitors, which elevate the risk of serious bleeding.

Subscribe to RSS - andexanet